Skip to content

Writing About Experiences and Health in Older Adults

Writing About Experiences and Health in Older Adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02472379
Enrollment
78
Registered
2015-06-15
Start date
2015-10-01
Completion date
2017-03-01
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Psychology

Keywords

Immune System, Behavioral Sciences, Women's Health, Health Psychology, Writing

Brief summary

UCLA researchers looking for healthy females (age 60+) to participate in a study investigating how writing about your experiences may be related to your health. Once a week for 6 weeks, participants will write about their experiences and fill out online questionnaires. Participants will also come to the UCLA campus for blood draws and to fill out questionnaires 3 times: once prior to the 6-week writing period, once immediately after the 6-week period, and once 2-months after the writing period.

Interventions

BEHAVIORALWriting: Group 1

Writing about experiences with familiar individuals in their lives, once a week for 6 weeks.

OTHERWriting: Group 2

Writing about experiences with familiar places, once a week for 6 weeks.

Sponsors

University of California, Los Angeles
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults 60 years and older

Exclusion criteria

* Following a structured telephone interview, participants with the following conditions will not be able to participate: 1. current smokers 2. active, uncontrolled medical disorders 3. chronic infection (e.g., Hepatitis C, HIV) 4. use of certain medications (e.g., hypnotic and psychotropic medication, steroid use, opioid use) 5. psychiatric disorders (e.g., current major depression, bipolar disorder) 6. body mass index (BMI) greater than 35 Other

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory activitybaseline, post 6-week writing period, 2-months post-writing periodChanges in proinflammatory cytokine and proinflammatory gene expression from blood draws
Health and well-being (self-report)baseline, post 6-week writing period, 2-months post-writing periodChanges in self-report measures of health (e.g., pain, sleep) and well-being (e.g., social support, depression)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNaomi I. Eisenberger, Ph.D.

University of California, Los Angeles

PRINCIPAL_INVESTIGATORMona Moieni, M.A.

University of California, Los Angeles

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026